Proacta Company

Proacta is a clinical-stage biopharmaceutical company developing hypoxia-activated ’prodrugs“ for the treatment of cancer.
Industry:
PharmTech
Technology:
Others
Funding Status:
Early Stage Venture
Investment Stage:
N/A
Investors Number:
7
Headquarters:
La Jolla, California, United States
Employee Number:
1-10
Number Of Exists:
N/A
Investor Type:
N/A
Total Funding:
$47M
Founded Date:
2004
Last Funding Type:
Debt Financing